Related Experiment Video
Updated: Jan 3, 2026

Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
[Amyloid β related angitis without marked leukoencephalopathy]
Yoko Taniguchi1, Taro Kitamura1, Hiroyasu Inoue1
1Department of Neurology, Nagoya City East Medical Center.
Abstract:
An 86-year-old woman was admitted to our hospital with headache and acute detarioration of consciousness. Cerebral microbleeds (CMBs) dominated the occipital lobe on the head MRI, revealing white matter lesions. It was accompanied by gadolinium (Gd) imaging effect in the leptomeninges and some CMBs. She was clinically diagnosed with amyloid β-related vasculitis and a good outcome was obtained with steroid therapy. Even when symptoms re-exacerbated, exacerbation of the contrast effect of CMBs was observed, but no white matter lesions appeared, and leptomeningeal enhancement did not change remarkably throughout the entire course.
Insights
This study reports a case of a patient with amyloid beta-related vasculitis presenting with neurological symptoms. Prompt steroid therapy led to a positive outcome, highlighting its efficacy in managing this rare condition.
Area of Science:
- Neurology
- Immunology
- Radiology
Background:
- Amyloid beta-related vasculitis is a rare inflammatory condition affecting cerebral blood vessels.
- Cerebral microbleeds (CMBs) and white matter lesions are potential MRI findings in vasculitis.
Observation:
- An 86-year-old woman presented with headache and altered consciousness.
- Head MRI revealed occipital lobe-dominant CMBs, white matter lesions, and leptomeningeal enhancement after gadolinium contrast.
Findings:
- The patient was diagnosed with amyloid beta-related vasculitis.
- Treatment with steroids resulted in a good clinical outcome.
- Symptom exacerbation correlated with increased CMB contrast enhancement but not new white matter lesions or leptomeningeal changes.
Implications:
- Steroid therapy appears effective for amyloid beta-related vasculitis.
- MRI findings, particularly CMBs and leptomeningeal enhancement, can aid in diagnosis and monitoring.
- Understanding the imaging evolution is crucial for managing this condition.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

